BLAUVELT, A.; STROBER, B.; LANGLEY, R.; KAVANAGH, S.; ARENDT, C.; BOEHNLEIN, M.; LEBWOHL, M.; REICH, K. Safety of Certolizumab Pegol in Plaque Psoriasis: Pooled 96-Week Data from Three Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1, CIMPASI-2 and CIMPACT). SKIN The Journal of Cutaneous Medicine, [S. l.], v. 3, p. S39, 2019. DOI: 10.25251/skin.3.supp.39. Disponível em: https://jofskin.org/33014/index.php/skin/article/view/766. Acesso em: 4 jul. 2024.